Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof

Abstract
Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof.
Description
BACKGROUND

Technical Field


The present disclosure relates to palladium complexes which are capable of absorbing and/or emitting light and are thus useful as an emissive or absorption material in a device.


Technical Background


Compounds capable of absorbing and/or emitting light are ideally suited for use in a wide variety of optical and electro-optical devices, including photo-absorbing devices such as solar and photo-sensitive devices, photo-emitting devices, such as organic light emitting diodes (OLEDs), or devices capable of both photo-absorption and emission. Much research has been devoted to the discovery and optimization of organic and organometallic materials for use in optical and electro-optical devices. Generally, research in this area aims to accomplish a number of goals, including improvements in absorption and emission efficiency, as well as improvements in processing ability, among others.


Despite significant advances in research devoted to optical and electro-optical materials, many current devices comprising organic or organometallic materials have yet to be optimized. Many materials currently used in optical and electro-optical devices have a number disadvantages, including poor processing ability, inefficient emission or absorption, and less than ideal stability, among others. Thus, a need exists for new materials which exhibit improved performance in optical and electro-optical devices. This need and other needs are satisfied by the compositions and methods of the present invention.


SUMMARY

The present invention relates to palladium complexes that exhibit photo-absorption and photo-emission, to methods of making such compounds, and to applications thereof, including optical devices comprising the compounds.


In one embodiment, the compounds are represented by the formula:




embedded image


wherein each R1 and R2 in (R1)2 and (R2)2 independently represents hydrogen, optionally substituted C1-C4 alkyl, halogen, hydroxyl, amino, nitro, or thiol;

    • R3 represents methyl, ethyl, propyl, or butyl;


Y1a represents O, S, NR4a, wherein R4a represents optionally substituted C1-C4 alkyl; Si(R4b)2, wherein each R4b in (R4b)2 independently represents optionally substituted C1-C4 alkyl; or C(R4c)2, wherein each R4c in (R4c)2 represents hydrogen or optionally substituted C1-C4 alkyl;


n is an integer 0 or 1;


Y1b when present, represents O, S, NR5a, wherein R5a represents optionally substituted C1-C4 alkyl; Si(R5b)2, wherein each R5b in (R5b)2 independently represents optionally substituted C1-C4 alkyl; or C(R5c)2, wherein each R5c in (R5c)2 represents hydrogen or optionally substituted C1-C4 alkyl;


each of Y2a, Y2b, Y2c, and Y2d independently represents N, NR6a, or CR6b, wherein each of R6a and R6b independently represents hydrogen, optionally substituted C1-C4 alkyl, halogen, hydroxyl, amino, nitro, or thiol;


each of Y3a, Y3b, Y3c, Y3d, Y3e, Y4a, Y4b, Y4c, and Y4d independently represents N, O, S, NR6a, CR6b, wherein each of R6a and R6b independently represents hydrogen or optionally substituted C1-C4 alkyl; or Z(R6c)2, wherein Z is C or Si, and wherein each R6c in (R6c)2 independently represents hydrogen or optionally substituted C1-C4 alkyl;


wherein m is an integer 1 or 2;


wherein the open dotted circle




embedded image



indicates partial or full unsaturation of the ring with which it is associated;


provided that if m is 1, each of Y2a and Y2d is CH and each of Y2b and Y2c is N, then at least one of Y4a, Y4b, Y3a, or Y3d is not N; and


provided that if n is 0, m is 2, each of Y2a and Y2d is CH, and each of Y2b and Y2c is N, then at least one of Y3b or Y3c is not N.


Also disclosed are optical devices, such as organic light emitting devices and luminescent display devices that comprise one or more compounds of the invention as a functional material, such as a light-emitter or absorber, or both.





BRIEF DESCRIPTION OF THE FIGURES

The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several aspects and together with the description serve to explain the principles of the invention.



FIG. 1 is a drawing of a cross-section of an exemplary organic light-emitting diode (OLED).



FIG. 2 is a photoluminescence spectrum produced from a specific embodiment, 2-(3-(pyridin-2-yl)phenoxy)-6-(pyridin-2-yloxy)phenyl]Pd(II) (Pd003) taken in degassed dichloromethane at room temperature, wherein the quantum yield was about 0.1 and the luminescence lifetime was about 11 μsec. The chemical structure of Pd003 is also illustrated in the inset.



FIG. 3 is a photoluminescence spectrum produced from a specific embodiment, 2-(3-(pyridin-2-yl)phenoxy)-6-(pyridin-2-yloxy)phenyl]Pd(II) (Pd003) doped into a polymethylmethacrylate (PMMA) thin film at room temperature, which shows a thin film photoluminescence quantum yield over 70%.



FIG. 4 illustrates (A) a specific embodiment, and (B) a photoluminescence spectrum of the same in a solution of dichloromethane, obtained at room temperature wherein the quantum yield was about 0.16 and the luminescent lifetime was about 30 μsec.



FIG. 5 illustrates (A) a specific embodiment, (B) an electroluminescent spectrum from a OLED device comprising the specific embodiment, (C) a plot of external quantum efficiency vs. current density for a Pd003 based device, and (D) a current vs. voltage plot at a 1% doping level.





Additional aspects of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or can be learned by practice of the invention. The advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.


DESCRIPTION

The present invention can be understood more readily by reference to the following detailed description of the invention and the Examples included therein.


Before the present compounds, devices, and/or methods are disclosed and described, it is to be understood that they are not limited to specific synthetic methods unless otherwise specified, or to particular reagents unless otherwise specified, as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, example methods and materials are now described.


As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a component” includes mixtures of two or more components.


Ranges can be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. It is also understood that there are a number of values disclosed herein, and that each value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.


As used herein, the terms “optional” or “optionally” means that the subsequently described event or circumstance can or can not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.


The term “alkyl” as used herein is a branched or unbranched saturated hydrocarbon group of 1 to 24 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dode cyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl group can be cyclic or acyclic. The alkyl group can be branched or unbranched. The alkyl group can also be substituted or unsubstituted. For example, the alkyl group can be substituted with one or more groups including, but not limited to, optionally substituted alkyl, cycloalkyl, alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, or thiol, as described herein. A “lower alkyl” group is an alkyl group containing from one to six (e.g., from one to four) carbon atoms.


The terms “amine” or “amino” as used herein are represented by the formula NA1A2A3, where A1, A2, and A3 can be, independently, hydrogen or optionally substituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.


The term “halide” as used herein refers to the halogens fluorine, chlorine, bromine, and iodine.


The term “hydroxyl” as used herein is represented by the formula —OH.


The term “nitro” as used herein is represented by the formula —NO2.


The term “nitrile” as used herein is represented by the formula —CN.


The term “thiol” as used herein is represented by the formula —SH.


Disclosed are the components to be used to prepare the compositions of the invention as well as the compositions themselves to be used within the methods disclosed herein. These and other materials are disclosed herein, and it is understood that when combinations, subsets, interactions, groups, etc. of these materials are disclosed that while specific reference of each various individual and collective combinations and permutation of these compounds can not be explicitly disclosed, each is specifically contemplated and described herein. For example, if a particular compound is disclosed and discussed and a number of modifications that can be made to a number of molecules including the compounds are discussed, specifically contemplated is each and every combination and permutation of the compound and the modifications that are possible unless specifically indicated to the contrary. Thus, if a class of molecules A, B, and C are disclosed as well as a class of molecules D, E, and F and an example of a combination molecule, A-D is disclosed, then even if each is not individually recited each is individually and collectively contemplated meaning combinations, A-E, A-F, B-D, B-E, B-F, C-D, C-E, and C-F are considered disclosed. Likewise, any subset or combination of these is also disclosed. Thus, for example, the sub-group of A-E, B-F, and C-E would be considered disclosed. This concept applies to all aspects of this application including, but not limited to, steps in methods of making and using the compositions of the invention. Thus, if there are a variety of additional steps that can be performed it is understood that each of these additional steps can be performed with any specific embodiment or combination of embodiments of the methods of the invention.


Throughout the specification, it should be understood that where letters and/or symbols are utilized to represent atoms or functional groups, and wherein multiple instances of the same letter and/or symbol are present, that each individual instance can represent the same or different species (e.g., atom and/or functional group) than any other instance using the same letter and/or symbol. Similarly, when a metal is depicted as a portion of a chemical structure, the notation can refer to a single metal atom and/or to a plurality of atoms. In one aspect, a notation for a metal refers to a single metal atom. In another aspect, a notation for a metal refers to a plurality of metal atoms.


In one aspect, the invention comprises phosphorescent multidentate, for example, tridentate and/or tetradentate, palladium (II) complexes. In another aspect, such multidentate palladium complexes can be modified and/or specifically tailored to tune the emission spectra from, for example, ultraviolet to near-infrared emission. In yet another aspect, the inventive compositions can provide improved stability and efficiency over conventional light emitting materials. In yet other aspects, the inventive compositions can be useful as luminescent labels, absorbers, emitters, or a combination thereof.


In one aspect, the inventive compositions are represented by the general formula:




embedded image


wherein Ar1, Ar2, Ar3, and Ar4, if present, represent aromatic groups, wherein each E represents an optional linking atom, such as, for example, carbon or oxygen, and wherein R, if present, represents an ancillary ligand


In various aspects, an ancillary ligand can comprise one or more of the following:




embedded image


embedded image


embedded image



wherein, R1-R10 of the ancillary ligand each independently represent a hydrogen atom, an alkyl group, a haloalkyl group, an aralkyl group, an alkenyl group, an alkynyl group, an aryl group, an amino group, a mono- or di-alkylamino group, a mono- or diaryl amino group, an alkoxy group, an aryloxy group, a heteroaryloxy group, an alkoxycarbonyl group, an acyloxy group, an acylamino group, an alkoxycarbonylamino group, an aryloxycarbonylamino group, a sulfonylamino group, a sulfamoyl group, a carbamoyl group, an alkylthio group, a sulfinyl group, a ureido group, a phosphoramide group, a hydroxyl group, a mercapto group, a halogen atom, a cyano group, a sulfo group, a carboxyl group, a nitro group, a hydrazino group, a substituted silyl group, or a polymerizable group; further, wherein a plurality of Rs exist, the number of R should be from 0 to about 4, and each R can be the same or different from any other R. In one aspect, an ancillary ligand can comprise a hydrogen atom. In another aspect, an ancillary ligand can comprise an alkyl group. In another aspect, an ancillary ligand can comprise a haloalkyl group. In another aspect, an ancillary ligand can comprise a aralkyl group. In another aspect, an ancillary ligand can comprise a alkenyl group. In another aspect, an ancillary ligand can comprise an alkynyl group. In another aspect, an ancillary ligand can comprise an aryl group. In another aspect, an ancillary ligand can comprise an amino group. In another aspect, an ancillary ligand can comprise an alkoxy group, an aryloxy group, a heteroaryloxy group, an alkoxycarbonyl group, an acyloxy group, or a combination thereof. In other aspects, an ancillary ligand can comprise an acylamino group, an alkoxycarbonylamino group, an aryloxycarbonylamino group, a sulfonylamino group, a sulfamoyl group, a carbamoyl group, an alkylthio group, a sulfinyl group, a ureido group, a phosphoramide group, a hydroxyl group, a mercapto group, a halogen atom, a cyano group, a sulfo group, a carboxyl group, a nitro group, a hydrazino group, a substituted silyl group, a polymerizable group, or a combination thereof.


In still other aspects, an ancillary ligand can comprise a group or groups difference from those specifically recited herein, and the present invention is not intended to be limited to any particular ancillary ligand.


In various aspects, specific non-limiting examples of the inventive composition can be grouped and illustrated by ligand class. In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, X represents a halogen or other electronegative group, and C represents an aromatic group. Specific examples of inventive compositions within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, X represents a halogen or other electronegative group, and C represents an aromatic group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and X represents a halogen or other electronegative group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, X represents a halogen or other electronegative group, and each C represents an aromatic group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each E represents an optional linking atom, such as, for example, carbon or oxygen, R represents an ancillary ligand, and each C represents an aromatic group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and each C represents an aromatic group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and each C represents an aromatic group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and each C represents an aromatic group. Specific examples of inventive composition within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and each C represents an aromatic group. A specific example of an inventive composition within this ligand class can comprise:




embedded image


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and C represents an aromatic group. Specific examples of inventive compositions within this ligand class can comprise:




embedded image



or a combination thereof.


In one aspect, the inventive composition can be represented by the general formula:




embedded image


wherein Pd represents palladium, each N represents a nitrogen substituted aromatic group, each E represents an optional linking atom, such as, for example, carbon or oxygen, and C represents an aromatic group. A specific example of an inventive composition within this ligand class can comprise:




embedded image


In another aspect, the compounds of the present invention are represented by the formula:




embedded image


In the above formula, each R1 and R2 in (R1)2 and (R2)2 independently represents hydrogen, optionally substituted C1-C4 alkyl, halogen, hydroxyl, amino, nitro, or thiol; Y1a represents O, S, NR4a, wherein R4a represents optionally substituted C1-C4 alkyl; Si(R4b)2, wherein each R4b in (R4b)2 independently represents optionally substituted C1-C4 alkyl; or C(R4c)2, wherein each R4c in (R4c)2 represents hydrogen or optionally substituted C1-C4 alkyl; n is an integer 0 or 1; Y1b, when present, represents O, S, NR5a, wherein R5a represents optionally substituted C1-C4 alkyl; Si(R5b)2, wherein each R5b in (R5b)2 independently represents optionally substituted C1-C4 alkyl; or C(R5c)2, wherein each R5c in (R5c)2 represents hydrogen or optionally substituted C1-C4 alkyl; each of Y2a, Y2b, Y2c, and Y2d independently represents N, NR6a, or CR6b, wherein each of R6a and R6b independently represents hydrogen, optionally substituted C1-C4 alkyl, halogen, hydroxyl, amino, nitro, or thiol; each of Y3a, Y3b, Y3c, Y3d, Y3e, Y4a, Y4b, Y4c, and Y4d independently represents N, O, S, NR6a, CR6b, wherein each of R6a and R6b independently represents hydrogen or optionally substituted C1-C4 alkyl; or Z(R6c)2, wherein Z is C or Si, and wherein each R6c in (R6c)2 independently represents hydrogen or optionally substituted C1-C4 alkyl; m is an integer 1 or 2; wherein the open dotted circle custom character indicates partial or full unsaturation of the ring with which it is associated.


In one embodiment of the formula above, if m is 1, each of Y2a and Y2d is CH and each of Y2b and Y2c is N, then at least one of Y4a, Y4b, Y3a, or Y3d is not N. For example, according to this embodiment, the following compound is not included in the above formula:




embedded image



As can be seen in the preceding example above, m is 1, each of Y2a and Y2d is CH and each of Y2b and Y2c is N; however, each of Y4a, Y4b, Y3a, or Y3d is N. It follows that the preceding example, according to this embodiment, is not included within the general formula above. In the practice of this embodiment, similar analysis can be used to determine whether or not a compound is or is not included within the general formula above.


In a further embodiment of the general formula above, if n is 0, m is 2, each of Y2a and Y2d is CH, and each of Y2b and Y2c is N, then at least one of Y3b or Y3c is not N. For example, according to this embodiment, the following compound is not included in the above formula:




embedded image



As can be seen in the preceding example above, n is 0, m is 2, each of Y2a and Y2d is CH, and each of Y2b and Y2c is N. However, each of Y3b and Y3c is N. It follows that the preceding example, according to this embodiment, is not included within the general formula above. Once more, in the practice of this embodiment, similar analysis can be used to determine whether or not a compound is or is not included within the general formula above.


In one embodiment of the general formula above, the compound is represented by the formula:




embedded image



Non-limiting examples of specific embodiments within this formula include:




embedded image


In another embodiment of the general formula above, the compound is represented by the formula:




embedded image



Non-limiting examples of specific embodiments within this formula include:




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


In another embodiment of the general formula above, the compound is represented by the formula:




embedded image



Non-limiting examples of specific embodiments within this formula include:




embedded image


In another embodiment of the general formula above, the compound is represented by the formula:




embedded image



Non-limiting examples of specific embodiments within this formula include:




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


In another embodiment of the general formula above, the compound is represented by the formula:




embedded image



Non-limiting examples of specific embodiments within this formula include:




embedded image


In another embodiment of the general formula above, the compound is represented by the formula:




embedded image



Non-limiting examples of specific embodiments within these formula include:




embedded image


In other aspects, any one or more of the general formulas and/or specific examples recited herein can be excluded from the invention. For example, in one aspect, the formula




embedded image



is not included in the present invention.


The compounds of the invention can be made using a variety of methods. In one embodiment, wherein Y1a is O, the compounds can be provided according to Scheme 1.




embedded image


With reference to Scheme 1, step “a” can be accomplished, for example, by using a catalytic amount of a coupling reagent, such as Cu2O, which couples alcohols, particularly phenols, with halogenated phenyl groups. The variable “X” in Scheme 1 above represents a halogen (i.e., Cl, F, I, Br), and is preferably I when used in conjunction with Scheme 1.


Each side of a ligand which complexes a metal can be made independently using a variety of methods, which, in one aspect, depend on whether Y3a is N or C. With reference to Scheme 2 below, when Y4a is N, the precursor can, in one aspect, be provided according to Scheme 2(A), wherein a halogenated phenyl compound is reacted with a pyrazole, imadazole, 1H-1,2,3-triazole, 1H-tetrazole, or 2H-pentazole. In such an aspect, the halogenated phenyl compound can comprise any halogen (X), including Cl, Br, F, or I, but is preferably I, which is typically more reactive in a coupling reaction. The halogenated phenyl compound and corresponding pyrazole, imadazole, 1H-1,2,3-triazole, 1H-tetrazole, or 2H-pentazole can be coupled using a metallic and/or organometallic coupling agent, such as, for example, Cu2O. During such a coupling reaction, it can, in one aspect, be advantageous to include an acid scavenger, such as, for example, syn-2-pyridinealdoxime, in a small molar ratio, for example, about 20 mol %.


In another aspect, when Y4a is C, a different protocol can be used to provide the precursor. With reference to Scheme 2(B) below, a halogenated phenyl, as discussed above can be reacted with a tetrazole, 1,2,3-triazole, pyrazole, or pyrrole to achieve a carbon-carbon bond coupling, as opposed to a carbon-nitrogen bond coupling as shown in Scheme 2(A). In one aspect, the carbon-carbon bond coupling can also be achieved using an organometallic catalyst, such as, for example, a Pd(II) catalyst (e.g., Pd(OAc)2) in a small molar ratio. In one aspect, such an organometallic catalyst can optionally be used together with an excess of a salt mixture, such as KI and/or CuI. As one of skill in the art can appreciate, when employing each of the coupling reactions shown in Scheme 2, it can, in various aspects, be advantageous to perform the reactions in a dry atmosphere, for example under argon, or even in a dry box to minimize and/or avoid moisture or oxygen inclusion.




embedded image


In one aspect, the compounds of the invention can be useful in a variety of optical applications. When utilized as light emitting materials, the inventive compounds can be useful in organic light emitting diodes (OLED)s, luminescent devices and displays, and/or other light emitting devices. With reference to FIG. 3, for example, a specific embodiment, 2-(3-(pyridin-2-yl)phenoxy)-6-(pyridin-2-yloxy)phenyl]Pd(II) exhibits photoluminescence (absorption of light followed by emission of light) across a range of wavelengths, including a narrow blue emission and other emission bands out to the red to near-IR region of the spectrum.


The emission (and absorption) profile of the compounds can be tuned by varying the structure of the ligand surrounding the metal center. For example, compounds having a ligand with electron withdrawing substituents can, in one aspect, generally exhibit different optical properties, including emission and absorption, than compounds having a ligand with electron donating substituents. Generally, a chemical structural change can affect the electronic structure of the compound, thereby affecting the absorption and emission properties of the compound. Thus, the compounds of the present invention can be tailored or tuned to a specific application that desires a particular emission or absorption characteristic. One of skill in the art, in possession of this disclosure, could readily design and/or select an appropriate multidentate palladium compound, in accordance with the various aspects described herein, to use in a particular application.


In one embodiment, the compounds can be used in an OLED. FIG. 1 illustrates a cross-sectional view of an exemplary OLED 100, which includes substrate 102 with an anode 104, which is typically a transparent material, such as indium tin oxide, a layer of hole-transporting material(s) (HTL) 106, a layer of light processing material 108, such as an emissive material (EML) including an emitter and a host, a layer of electron-transporting material(s) (ETL) 110, and a metal cathode layer 112.


In such an embodiment, the layer of light processing material 108 can comprise one or more compounds of the present invention optionally together with a host material. The host material, if present, can be any suitable host material known in the art. The emission color of an OLED can be determined by the emission energy (optical energy gap) of the light processing material 108, which as discussed above can be tuned by tuning the electronic structure of the emitting compounds and/or the host material. Both the hole-transporting material in the HTL layer 106 and the electron-transporting material(s) in the ETL layer 110 can comprise any suitable hole-transporter known in the art. A selection of which is well within the purview of those skilled in the art.


It will be apparent that the compounds of the present invention can exhibit phosphorescence. Phosphorescent OLEDs (i.e., OLEDs with phosphorescent emitters) typically have higher device efficiencies that other OLEDs, such as fluorescent OLEDs. Light emitting devices based on electrophosphorescent emitters are described in more detail in WO2000/070655 to Baldo et al., which is incorporated herein by this reference for its teaching of OLEDs, and in particular phosphorescent OLEDs.


EXAMPLES

The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how the compounds, compositions, articles, devices and/or methods claimed herein are made and evaluated, and are intended to be purely exemplary of the invention and are not intended to limit the scope of what the inventors regard as their invention. Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.), but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in ° C. or is at ambient temperature, and pressure is at or near atmospheric.


Example 1. Preparation of Specific Embodiment 2-(3-(pyridin-2-yl)phenoxy)-6-(pyridin-2-yloxy)phenyl]Pd(II)
Synthesis of 3-(pyridin-2-yloxy)phenol



embedded image


Under a nitrogen atmosphere, a pressure vessel was charged with a magnetic stir bar, resorcinol (110 mmol), 2-bromopyridine (100 mmol), 1-methylimidazole (5 mmol), and potassium carbonate (200 mmol). Pyridine (80 mL) was added and bubbled with nitrogen for 20 minutes before copper(I) iodide (10 mmol) was added and bubbled 10 minutes further. The vessel was sealed and heated to 140° C. while stirring. After 2 days, the solution was allowed to cool. The solids were filtered off and rinsed with a 50:50 mixture of toluene and methanol. The filtrate was reduced by rotary evaporation and 150 ml of water containing 10 mL glacial acetic acid was added and shaken vigorously. The water was decanted off and 50 mL of DCM was added, forming an off white precipitate which was collected by vacuum filtration and dried with ether, resulting in the pure product 3-(pyridin-2-yloxy)phenol with a 55% yield. 1H NMR (CDCl3): 5.98 (s, 1H), 6.59 (s, 1H), 6.62-6.69 (m, 2H), 6.94 (d, 1H), f 7.02 (dd, 1H), 7.23 (vt, 1H), 7.70 (dd, 1H), 8.23 (b, 1H)


Synthesis of 2-(3-(3-bromophenoxy)phenoxy)pyridine



embedded image


Under a nitrogen atmosphere, a pressure vessel was charged with a magnetic stir bar, 3-(pyridin-2-yloxy)phenol (50 mmol), 2,6-dibromopyridine (50 mmol), 1-methylimidazole (25 mmol), and potassium carbonate (100 mmol). Toluene (80 mL) was added and bubbled with nitrogen for 20 minutes before copper(I) iodide (5 mmol) was added and the solution bubbled for 10 minutes further. The vessel was sealed and heated to 140° C. while stirring. After 2 days, the solution was allowed to cool and the solids were filtered off and rinsed with dichloromethane. The filtrate was added to a separatory funnel containing DCM and water. The water phase was washed 3 times with 75 mL DCM, and the combined organic layers were washed once with pure water. The organic layer was collected, dried with magnesium sulfate, filtered, and the filtrate reduced by rotary evaporation. The resulting oil was purified by column chromatography using DCM over silica resulting in the pure product 2-(3-(3-bromophenoxy)phenoxy)pyridine with a 60% yield. 1H NMR (CDCl3): 6.80-6.85 (m, 2H), 6.91 (s, 1H), 6.94 (s, 1H), 6.97-7.03 (m, 2H), 7.19 (vt, 1H), 7.21-7.24 (m, 2H), 7.36 (vt, 1H), 7.70 (dd, 1H), 8.21 (dd, 1H).


Synthesis of 2-(3-(3-(pyridin-2-yl)phenoxy)phenoxy)pyridine



embedded image


Under a nitrogen atmosphere, an oven dried three neck flask was charged with a magnetic stir bar, 2-(3-(3-bromophenoxy)phenoxy) (10 mmol), and 2-(tripropylstannyl)pyridine (10 mmol). Dry toluene (100 mL) was added and bubbled with nitrogen for 20 minutes before Tetrakis(triphenylphosphine)palladium(0) (0.5 mmol) was added, bubbled 10 minutes further, and brought to reflux for 2 days. After cooling, the contents of the flask were filtered, the liquid reduced by rotary evaporation, and the resulting oil was purified by column chromatography using DCM over silica to yield the pure product 2-(3-(3-(pyridin-2-yl)phenoxy)phenoxy)pyridine with a 65% yield. 1H NMR (CDCl3): 6.84 (vt, 1H), 6.85-6.89 (m, 2H), 6.91 (d, 1H), 6.98 (dd, 1H), 7.11 (dd, 1H), 7.24 (dd, 1H), 7.34 (vt, 1H), 7.44 (vt, 1H), 7.66-7.78 (m, 5H), 8.19 (dd, 1H), 8.67 (dd, 1H).


Synthesis of [2-(3-(pyridin-2-yl)phenoxy)-6-(pyridin-2-yloxy)phenyl]Pd(II)



embedded image


A mixture of 2-(3-(3-(pyridin-2-yl)phenoxy)phenoxy)pyridine (1 mmol), K2PdCl4 (1 mmol), and acetic acid (10 mL) was refluxed for 3 days. The mixture was allowed to cool to room temperature. The resulting white complex was filtered off and washed with H2O, MeOH, and Et2O, and dried under vacuum to 2-(3-(pyridin-2-yl)phenoxy)-6-(pyridin-2-yloxy)phenyl]Pd(II). The product was purified by sublimation for further testing.

Claims
  • 1. A compound represented by the formula:
  • 2. An organic light-emitting diode (OLED) comprising, as an emissive material, a compound represented by the formula of claim 1.
  • 3. An organic photovoltaic device comprising, as a donor or acceptor material, a compound represented by the formula of claim 1.
  • 4. The compound of claim 1, which is represented by the formula:
  • 5. The compound of claim 1, which is represented by the formula:
  • 6. An organic light-emitting diode (OLED) comprising, as an emissive material, a compound represented by the formula of claim 4.
  • 7. An organic photovoltaic device comprising, as a donor or acceptor material, a compound represented by the formula of claim 4.
  • 8. The compound of claim 1, wherein the compound is represented by the formula:
  • 9. The compound of claim 1, wherein Y2a, Y2b, Y2c, and Y2d are N.
  • 10. The compound of claim 1, wherein Y2a, Y2b, Y2c, and Y2d are C or CH.
  • 11. The compound of claim 1, wherein one of Y2a, Y2b, Y2c, and Y2d is N and the others are C or CH.
  • 12. The compound of claim 1, wherein two of Y2a, Y2b, Y2c, and Y2d are N and the others are C or CH.
  • 13. The compound of claim 1, wherein three of Y2a, Y2b, Y2c, and Y2d are N and the other is C or CH.
  • 14. The compound of claim 1, wherein the ring which comprises Y3a, Y3b, Y3c, Y3d, and Y3e groups is a heteroaryl group having one nitrogen atom.
  • 15. The compound of claim 1, wherein the ring which comprises Y3a, Y3b, Y3c, Y3d, and Y3e groups is a heteroaryl group having two nitrogen atoms.
  • 16. The compound of claim 1, wherein the ring which comprises Y3a, Y3b, Y3c, Y3d, and Y3e groups is a pyrazolyl group.
  • 17. The compound of claim 1, wherein the ring which comprises Y4a, Y4b, Y4c, and Y4d groups is a heteroaryl group having one nitrogen atom.
  • 18. The compound of claim 1, wherein the ring which comprises Y4a, Y4b, Y4c, and Y4d groups is a heteroaryl group having two nitrogen atoms.
  • 19. The compound of claim 1, wherein the ring which comprises Y4a, Y4b, Y4c, and Y4d groups is a pyrazolyl group.
  • 20. The compound of claim 1, which is represented by the formula:
  • 21. The compound of claim 1, which is represented by the formula:
  • 22. The compound of claim 1, which is represented by the formula:
  • 23. The compound of claim 1, which is represented by the formula:
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a Continuation of U.S. patent application Ser. No. 14/145,461, filed Dec. 31, 2013, now U.S. Pat. No. 9,382,273, which is a Continuation of U.S. patent application Ser. No. 13/695,337, filed Mar. 13, 2013, now abandoned, which claims priority to and is a U.S. National Phase Application of International Application No. PCT/US2011/034776, filed May 2, 2011, which claims priority to U.S. Patent Application No. 61/329,684, filed Apr. 30, 2010, all of which application are incorporated herein fully by this reference.

US Referenced Citations (103)
Number Name Date Kind
4769292 Tang et al. Sep 1988 A
5707745 Forrest et al. Jan 1998 A
5844363 Gu et al. Dec 1998 A
6200695 Arai et al. Mar 2001 B1
6303238 Thompson et al. Oct 2001 B1
6780528 Tsuboyama et al. Aug 2004 B2
7002013 Chi et al. Feb 2006 B1
7037599 Culligan et al. May 2006 B2
7279704 Walters et al. Oct 2007 B2
7332232 Ma et al. Feb 2008 B2
7442797 Itoh et al. Oct 2008 B2
7501190 Ise Mar 2009 B2
7655322 Forrest et al. Feb 2010 B2
7947383 Ise et al. May 2011 B2
8389725 Li et al. Mar 2013 B2
8617723 Stoessel Dec 2013 B2
8816080 Li et al. Aug 2014 B2
8871361 Xia et al. Oct 2014 B2
8927713 Li et al. Jan 2015 B2
8946417 Li et al. Feb 2015 B2
9059412 Zeng et al. Jun 2015 B2
9224963 Li et al. Dec 2015 B2
9238668 Li et al. Jan 2016 B2
9312505 Brooks et al. Apr 2016 B2
9324957 Li et al. Apr 2016 B2
9382273 Li Jul 2016 B2
9385329 Li et al. Jul 2016 B2
9425415 Li et al. Aug 2016 B2
9461254 Tsai et al. Oct 2016 B2
9550801 Li et al. Jan 2017 B2
9617291 Li et al. Apr 2017 B2
20020068190 Tsuboyama et al. Jun 2002 A1
20030062519 Yamazaki et al. Apr 2003 A1
20030186077 Chen Oct 2003 A1
20050170207 Ma et al. Aug 2005 A1
20050260446 Mackenzie et al. Nov 2005 A1
20060073359 Ise et al. Apr 2006 A1
20060094875 Itoh et al. May 2006 A1
20060202197 Nakayama et al. Sep 2006 A1
20060210831 Sano et al. Sep 2006 A1
20060263635 Ise Nov 2006 A1
20060286406 Igarashi et al. Dec 2006 A1
20070057630 Nishita et al. Mar 2007 A1
20070059551 Yamazaki Mar 2007 A1
20070082284 Stoessel et al. Apr 2007 A1
20070103060 Itoh et al. May 2007 A1
20080001530 Ise et al. Jan 2008 A1
20080036373 Itoh et al. Feb 2008 A1
20080054799 Satou Mar 2008 A1
20080079358 Satou Apr 2008 A1
20080241518 Satou et al. Oct 2008 A1
20080241589 Fukunaga et al. Oct 2008 A1
20090026936 Satou et al. Jan 2009 A1
20090026939 Kinoshita et al. Jan 2009 A1
20090032989 Karim et al. Feb 2009 A1
20090039768 Igarashi et al. Feb 2009 A1
20090079340 Kinoshita et al. Mar 2009 A1
20090128008 Ise et al. May 2009 A1
20090218561 Kitamura et al. Sep 2009 A1
20090261721 Murakami et al. Oct 2009 A1
20090267500 Kinoshita et al. Oct 2009 A1
20100000606 Thompson et al. Jan 2010 A1
20100013386 Thompson et al. Jan 2010 A1
20100171111 Takada et al. Jul 2010 A1
20120095232 Li et al. Apr 2012 A1
20120181528 Takada et al. Jul 2012 A1
20120215001 Li et al. Aug 2012 A1
20120223634 Xia et al. Sep 2012 A1
20120302753 Li Nov 2012 A1
20130048963 Beers et al. Feb 2013 A1
20130168656 Tsai et al. Jul 2013 A1
20130203996 Li et al. Aug 2013 A1
20130237706 Li Sep 2013 A1
20130341600 Lin et al. Dec 2013 A1
20140014922 Lin et al. Jan 2014 A1
20140027733 Zeng et al. Jan 2014 A1
20140084261 Brooks et al. Mar 2014 A1
20140114072 Li et al. Apr 2014 A1
20140203248 Zhou et al. Jul 2014 A1
20140330019 Li et al. Nov 2014 A1
20140364605 Li et al. Dec 2014 A1
20150008419 Li Jan 2015 A1
20150028323 Xia et al. Jan 2015 A1
20150069334 Xia et al. Mar 2015 A1
20150105556 Li et al. Apr 2015 A1
20150162552 Li et al. Jun 2015 A1
20150194616 Li et al. Jul 2015 A1
20150228914 Li et al. Aug 2015 A1
20150287938 Li et al. Oct 2015 A1
20150318500 Li Nov 2015 A1
20150349279 Li et al. Dec 2015 A1
20160028028 Li et al. Jan 2016 A1
20160043331 Li et al. Feb 2016 A1
20160072082 Brooks et al. Mar 2016 A1
20160133862 Li et al. May 2016 A1
20160197291 Li Jul 2016 A1
20160285015 Li et al. Sep 2016 A1
20160359120 Li Dec 2016 A1
20160359125 Li et al. Dec 2016 A1
20170012224 Li et al. Jan 2017 A1
20170047533 Li et al. Feb 2017 A1
20170066792 Li et al. Mar 2017 A1
20170069855 Li Mar 2017 A1
Foreign Referenced Citations (114)
Number Date Country
1777663 May 2006 CN
1894269 Jan 2007 CN
101142223 Mar 2008 CN
101667626 Mar 2010 CN
102449108 May 2012 CN
102892860 Jan 2013 CN
102971396 Mar 2013 CN
104232076 Dec 2014 CN
104693243 Jun 2015 CN
105367605 Mar 2016 CN
105418591 Mar 2016 CN
1808052 Jul 2007 EP
1874893 Jan 2008 EP
1874894 Jan 2008 EP
1919928 May 2008 EP
2036907 Mar 2009 EP
2096690 Sep 2009 EP
2417217 Feb 2012 EP
2112213 Jul 2012 EP
2711999 Mar 2014 EP
2005267557 Sep 2005 JP
200531073 Nov 2005 JP
2006047240 Feb 2006 JP
2006232784 Sep 2006 JP
2006242080 Sep 2006 JP
2006242081 Sep 2006 JP
2006256999 Sep 2006 JP
2006257238 Sep 2006 JP
2006261623 Sep 2006 JP
2006290988 Oct 2006 JP
2006313796 Nov 2006 JP
2006332622 Dec 2006 JP
2006351638 Dec 2006 JP
2007019462 Jan 2007 JP
2007042875 Feb 2007 JP
2007053132 Mar 2007 JP
2007066581 Mar 2007 JP
2007073620 Mar 2007 JP
2007073845 Mar 2007 JP
2007073900 Mar 2007 JP
2007080593 Mar 2007 JP
2007080677 Mar 2007 JP
2007088105 Apr 2007 JP
2007088164 Apr 2007 JP
2007096259 Apr 2007 JP
2007110067 Apr 2007 JP
2007110102 Apr 2007 JP
2007258550 Oct 2007 JP
2007324309 Dec 2007 JP
2008010353 Jan 2008 JP
2008091860 Apr 2008 JP
2008103535 May 2008 JP
2008108617 May 2008 JP
2008109085 May 2008 JP
2008109103 May 2008 JP
2008160087 Jul 2008 JP
2008198801 Aug 2008 JP
2008270729 Nov 2008 JP
2008270736 Nov 2008 JP
2009016184 Jan 2009 JP
2009016579 Jan 2009 JP
2009032977 Feb 2009 JP
2009032988 Feb 2009 JP
2009266943 Nov 2009 JP
2009267171 Nov 2009 JP
2009267244 Nov 2009 JP
2009272339 Nov 2009 JP
2009283891 Dec 2009 JP
2010135689 Jun 2010 JP
2012222255 Nov 2012 JP
2013525436 Jun 2013 JP
5604505 Oct 2014 JP
2014221807 Nov 2014 JP
2015081257 Apr 2015 JP
1020060115371 Nov 2006 KR
2007061830 Jun 2007 KR
2007112465 Nov 2007 KR
1020130043460 Apr 2013 KR
200701835 Jan 2007 TW
201307365 Feb 2013 TW
201710277 Mar 2017 TW
WO0070655 Nov 2000 WO
WO2004003108 Jan 2004 WO
WO2004108857 Dec 2004 WO
WO2005042444 May 2005 WO
WO2005042550 May 2005 WO
WO2006033440 Mar 2006 WO
WO2006098505 Sep 2006 WO
WO2006115299 Nov 2006 WO
WO2006115301 Nov 2006 WO
WO2007034985 Mar 2007 WO
WO2007069498 Jun 2007 WO
WO2008066192 Jun 2008 WO
WO2008066195 Jun 2008 WO
WO2008066196 Jun 2008 WO
WO2008117889 Oct 2008 WO
WO2008123540 Oct 2008 WO
WO2009017211 Feb 2009 WO
WO2010118026 Oct 2010 WO
WO2011137429 Nov 2011 WO
WO2011137431 Nov 2011 WO
WO2012112853 Aug 2012 WO
WO2012142387 Oct 2012 WO
WO2012162488 Nov 2012 WO
WO2012163471 Dec 2012 WO
WO2013130483 Sep 2013 WO
WO2014016611 Jan 2014 WO
WO2014031977 Feb 2014 WO
WO2014047616 Mar 2014 WO
WO2014109814 Jul 2014 WO
WO2015027060 Feb 2015 WO
WO2015131158 Sep 2015 WO
WO2016025921 Feb 2016 WO
WO2016029186 Feb 2016 WO
Non-Patent Literature Citations (42)
Entry
Wong; Journal of Organometallic Chemistry 2009, 694, 2644-2647.
Marc Lepeltier et al., “Efficient blue green organic light-emitting devices based on a monofluorinated heteroleptic ridium(III) complex,” Synthetic Metals, vol. 199, 2015, pp. 139-146.
Stefan Bernhard, “The First Six Years: A Report,” Department of Chemistry, Princeton University, May 2008, 11 pages.
Non-Final Rejection dated Jul. 1, 2013 for U.S. Appl. No. 13/695,337, filed May 2, 2011 (Applicants—Arizona Technology Enterprises (AZTE); Inventors—Li et al.; (28 pages).
Preliminary Amendment filed on Oct. 30, 2012 for U.S. Appl. No. 13/695,337, filed May 2, 2011 (Applicants—Arizona Technology Enterprises (AZTE); Inventors—Li et al.; (4 pages).
International Preliminary Report on Patentability dated Nov. 6, 2012 for Intl. Pat. App. No. PCT/US2011/034776 filed May 2, 2011 and published as WO 2011/137429 dated Nov. 3, 2011 (Applicants—Arizona Board of Regents Acting for and on behalf of Arizona State University; Inventors—Li et al.; (6 pages).
International Search Report dated Feb. 9, 2012 for Intl. Pat. App. No. PCT/US2011/034776 filed May 2, 2011 and published as WO 2011/137429 dated Nov. 3, 2011 (Applicants—Arizona Board of Regents Acting for and on behalf of Arizona State University; Inventors—Li et al.; (3 pages).
Written Opinion dated Feb. 9, 2012 for Intl. Pat. App. No. PCT/US2011/034776 filed May 2, 2011 and published as WO 2011/137429 dated Nov. 3, 2011 (Applicants—Arizona Board of Regents Acting for and on behalf of Arizona State University; Inventors—Li et al.; (5 pages).
First Office Action (and English Translation) for Chinese Application No. 201180023966.1, dated Feb. 7, 2014, 14 pages.
Second Office Action (and English Translation) for Chinese Application No. 201180023966.1, dated Dec. 22, 2014, 8 pages.
Official Action (and English Translation) issued by the Japanese Patent Office dated Mar. 11, 2015 for Pat. App. No. 2013-508082 filed May 2, 2011, 16 pages.
Third Office Action (and English Translation) for Chinese Application No. 201180023966.1, dated Sep. 1, 2015, 7 pages.
Final Rejection (and English Translation) issued by the Japanese Patent Office dated Oct. 30, 2015 for Pat. App. No. 2013-508082, 6 pages.
Wong; Challenges in organometallic research—Great opportunity for solar cells and OLEDs, Journal of Organometallic Chemistry, 2009, 694, 2644-2647.
JP2009267244, English Translation from EPO, dated Nov. 2009, 80 pages.
JP2010135689, English translation from EPO, dated Jun. 2010, 95 pages.
Chi et al.; Transition-metal phosphors with cyclometalating ligands: fundamentals and applications, Chemical Society Reviews, vol. 39, No. 2, Feb. 2010, pp. 638-655.
Dorwald; Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, 2005, Wiley-VCH.
Satake et al., “Interconvertible Cationic and Neutral Pyridinylimidazole η3-Allylpalladium Complexes. Structural Assignment by 1H, 13C, and 15N NMR and X-ray Diffraction”, Organometallics, vol. 18, No. 24, 1999, pp. 5108-5111.
Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, Sep. 10, 1998, pp. 151-154.
Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Applied Physics Letters, vol. 75, No. 1, Jul. 5, 1999, pp. 4-6.
Ying Yang et al., “Induction of Circularly Polarized Electroluminescence from an Achiral Light-Emitting Polymer via a Chiral Small-Molecule Dopant,” Advanced Materials, vol. 25, Issue 18, May 14, 2013, pp. 2624-2628.
Ayan Maity et al., “Room-temperature synthesis of cyclometalated iridium(III) complexes; kinetic isomers and reactive functionalities” Chem. Sci., vol. 4, pp. 1175-1181 (2013).
Shiro Koseki et al., “Spin-orbit coupling analyses of the geometrical effects on phosphorescence in Ir(ppy)3 and its derivatives”, J. Phys. Chem. C, vol. 117, pp. 5314-5327 (2013).
Ji Hyun Seo et al., “Efficient blue-green organic light-emitting diodes based on heteroleptic tris-cyclometalated iridium (III) complexes”. Thin Solid Films, vol. 517, pp. 1807-1810 (2009).
Barry O'Brien et al.: White organic light emitting diodes using Pt-based red, green and blue phosphorescent dopants. Proc. SPIE, vol. 8829, pp. 1-6, Aug. 25, 2013.
Vanessa Wood et al., “Colloidal quantum dot light-emitting devices,” Nano Reviews , vol. 1, 2010, 8 pages.
Glauco Ponterini et al., “Comparison of Radiationless Decay Processes in Osmium and Platinum Porphyrins,” J. Am. Chem. Soc., vol. 105, No. 14, 1983, pp. 4639-4645.
Shizuo Tokito et al., “Confinement of triplet energy on phosphorescent molecules for highly-efficient organic blue-light-emitting devices,” Applied Physics Letters, vol. 83, No. 3, Jul. 21, 2003, pp. 569-571.
Brian W. D'Andrade et al., “Controlling Exciton Diffusion in Multilayer White Phosphorescent Organic Light Emitting Devices,” Adv. Mater. , vol. 14, No. 2, Jan. 16, 2002, pp. 147-151.
Dileep A. K. Vezzu et al., “Highly Luminescent Tetradentate Bis-Cyclometalated Platinum Complexes: Design, Synthesis, Structure, Photophysics, and Electroluminescence Application,” Inorg. Chem., vol. 49, 2010, pp. 5107-5119.
Evan L. Williams et al., “Excimer-Based White Phosphorescent Organic Light Emitting Diodes with Nearly 100% Internal Quantum Efficiency,” Adv. Mater., vol. 19, 2007, pp. 197-202.
Shih-Chun Lo et al., “High-Triplet-Energy Dendrons: Enhancing the Luminescence of Deep Blue Phosphorescent Iridium(III) Complexes,” J. Am. Chem. Soc., vol. 131, 2009, pp. 16681-16688.
Jan Kalinowski et al., “Light-emitting devices based on organometallic platinum complexes as emitters,” Coordination Chemistry Reviews, vol. 255, 2011, pp. 2401-2425.
Ke Feng et al., “Norbornene-Based Copolymers Containing Platinum Complexes and Bis(carbazolyl)benzene Groups in Their Side-Chains,” Macromolecules, vol. 42, 2009, pp. 6855-6864.
Chi-Ming Che et al., “Photophysical Properties and OLED Applications of Phosphorescent Platinum(II) Schiff Base Complexes,” Chem. Eur. J., vol. 16, 2010, pp. 233-247.
Stephen R. Forrest, “The path to ubiquitous and low-cost organic electronic appliances on plastic,” Nature, vol. 428, Apr. 29, 2004, pp. 911-918.
Nicholas R. Evans et al., “Triplet Energy Back Transfer in Conjugated Polymers with Pendant Phosphorescent Iridium Complexes,” J. Am. Chem. Soc., vol. 128, 2006, pp. 6647-6656.
Xiaofan Ren et al., “Ultrahigh Energy Gap Hosts in Deep Blue Organic Electrophosphorescent Devices,” Chem. Mater., vol. 16, 2004, pp. 4743-4747.
Dorwald; “Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design,” Chapter 1, 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Wienheim, 32 pages.
Murakami; JP 2007258550, English machine translation from EPO, dated Oct. 4, 2007. 80 pages.
Murakami; JP 2007324309, English machine translation from EPO, dated Dec. 13, 2007, 89 pages.
Related Publications (1)
Number Date Country
20170005278 A1 Jan 2017 US
Provisional Applications (1)
Number Date Country
61329684 Apr 2010 US
Continuations (2)
Number Date Country
Parent 14145461 Dec 2013 US
Child 15202058 US
Parent 13695337 US
Child 14145461 US